Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 107.16% is 137% above its 4-year average of 45.29%, around the middle of its 4-year range (9.81%–294.95%).
As of the fiscal period ended Friday, July 31, 2026. 92.72% above its 12-month average of 55.60%.
Reported quarterly debt to assets ratio; no daily interpolation. Q1 FY2027 (2026-07-31): 107.16%.
DEBT TO ASSETS RATIO
107.16%
DEBT TO ASSETS RATIO AVG TTM
55.60%
DEBT TO ASSETS RATIO AVG 3Y
47.44%
DEBT TO ASSETS RATIO AVG 5Y
45.29%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+92.72%
CURRENT VS 3Y AVG
+125.85%
CURRENT VS 5Y AVG
+136.60%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+118962.36%
vs the sector median at left
HeartSciences Inc.
Market Cap
$8.25M
Debt to Assets Ratio
107.16%
TTM Avg
55.60%
3Y Avg
47.44%
5Y Avg
45.29%
Market Cap
$8.35M
Debt to Assets Ratio
0.18%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.86M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.76M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.74M
Debt to Assets Ratio
0.05%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.64M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| HeartSciences Inc. (HSCS) | $8.25M | 107.16% | 55.60% | 47.44% | 45.29% |
| DataMEDS AI, Inc. (MEDS)vs › | $8.29M | 1.00% | N/A | N/A | N/A |
| GT Biopharma, Inc. (GTBP)vs › | $8.10M | 0.00% | N/A | N/A | N/A |
| Healthcare Triangle, Inc. (HCTI)vs › | $8.35M | 0.18% | N/A | N/A | N/A |
| Traws Pharma, Inc. (TRAW)vs › | $7.94M | 0.00% | N/A | N/A | N/A |
| Aprea Therapeutics, Inc. (APRE)vs › | $7.86M | 0.00% | N/A | N/A | N/A |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.76M | 0.00% | N/A | N/A | N/A |
| ENDRA Life Sciences Inc. (NDRA)vs › | $7.74M | 0.05% | N/A | N/A | N/A |
| Quince Therapeutics, Inc. (QNCX)vs › | $7.64M | 0.00% | N/A | N/A | N/A |
| Advanced Biomed Inc. Common Stock (ADVB)vs › | $8.90M | 0.07% | N/A | N/A | N/A |
Debt/Assets
107.2%
Debt/Equity
N/A
Current Ratio
0.12
Interest Coverage
-11.2x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-07-31 | 107.16% |
| 2026-04-30 | 74.80% |
| 2026-01-31 | 51.19% |
| 2025-10-31 | 14.61% |
| 2025-07-31 | 30.24% |
| 2025-04-30 | 70.69% |
| 2025-01-31 | 52.37% |
| 2024-10-31 | 37.33% |
| 2024-07-31 | 12.36% |
| 2024-04-30 | 10.91% |
| 2024-01-31 | 9.81% |
| 2023-10-31 | 84.38% |
| 2023-07-31 | 60.94% |
| 2023-04-30 | 47.63% |
| 2023-01-31 | 48.25% |
| 2022-10-31 | 35.85% |
| 2022-07-31 | 21.40% |
| 2022-04-30 | 294.95% |
| 2021-04-30 | 159.74% |
